Elypta logotype


The first Metabolism-based liquid biopsy.

Elypta is developing the first-ever metabolism-based liquid biopsy platform for early detection and closer follow-up of multiple cancer indications. The platform is inherently safe and convenient, exceptionally sensitive in studies to date and affordable assay technology allows for broad use.

Read more about Elypta here.


Go back